Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Drayson

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Leukemia|August 27, 2005
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitorsC A Bradbury, F L Khanim, R Hayden, et al.
Brain, Behavior, and Immunity|December 3, 2014
Negative affectivity predicts decreased pain tolerance during low-grade inflammation in healthy womenT E Lacourt, J H Houtveen, J J C S Veldhuijzen van Zanten, et al.
Leukemia|March 21, 2003
Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new diseaseS L Fenton, Q T Luong, A Sarafeim, et al.
Leukemia|October 17, 2008
Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2R E Hayden, G Pratt, N J Davies, et al.
Blood Cancer Journal|July 26, 2012
Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain productionF L Khanim, B A M E Merrick, H V Giles, et al.
Blood Cancer Journal|March 19, 2024
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometryH V Giles, M T Drayson, B Kishore, et al.
BMC Cancer|February 5, 2024
The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot studyA Emery, S Moore, J Crowe, et al.
Journal of Dental Research|June 2, 2021
COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care ProfessionalsA M Shields, S E Faustini, C A Kristunas, et al.
Journal of Immunological Methods|March 29, 2021
Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patientsA M Cook, S E Faustini, L J Williams, et al.
Blood Cancer Journal|December 10, 2016
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trialJ R Jones, D A Cairns, W M Gregory, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Leukemia|August 27, 2005
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitorsC A Bradbury, F L Khanim, R Hayden, et al.
Brain, Behavior, and Immunity|December 3, 2014
Negative affectivity predicts decreased pain tolerance during low-grade inflammation in healthy womenT E Lacourt, J H Houtveen, J J C S Veldhuijzen van Zanten, et al.
Leukemia|March 21, 2003
Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new diseaseS L Fenton, Q T Luong, A Sarafeim, et al.
Leukemia|October 17, 2008
Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2R E Hayden, G Pratt, N J Davies, et al.
Blood Cancer Journal|July 26, 2012
Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain productionF L Khanim, B A M E Merrick, H V Giles, et al.
Blood Cancer Journal|March 19, 2024
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometryH V Giles, M T Drayson, B Kishore, et al.
BMC Cancer|February 5, 2024
The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot studyA Emery, S Moore, J Crowe, et al.
Journal of Dental Research|June 2, 2021
COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care ProfessionalsA M Shields, S E Faustini, C A Kristunas, et al.
Journal of Immunological Methods|March 29, 2021
Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patientsA M Cook, S E Faustini, L J Williams, et al.
Blood Cancer Journal|December 10, 2016
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trialJ R Jones, D A Cairns, W M Gregory, et al.
Pageof 5